UnitedHealth Aktie News

Top executives from five of the nation's largest health insurers began testifying on Thursday to lawmakers in both the U.S. House of Representatives and Senate about the rising costs of Americans' healthcare and declining affordability.

UnitedHealth Group Inc. will provide rebates to its Obamacare plan members in 2026, company CEO Stephen Hemsley said in a prepared testimony released Wednesday.

While the hopes that 2025 growth will persist in 2026 haven't been entirely obliterated, the stock market bloodbath of the January 20 session made investors feel less greedy and open to considering being fearful, according to the January 21 ‘Fear and Greed Index.'

Undercovered Dozen: Dell, Brighthouse, UnitedHealth, And More

UnitedHealth Group (NYSE: UNH) remains in focus ahead of the health insurance company's Q4 earnings scheduled for next week on January 27th. But for long-term investors, its upcoming earnings – even if they beat expectations – may not mean much given the macro environment is turning against UNH under the Trump administration.

All eyes are on UnitedHealth Group for signs the company – and the health insurance industry as a whole – are getting a handle on rising costs that have dogged the nation's giant health insurers for the last two years.

UnitedHealth experienced a significant rise in healthcare costs last year, resulting in margin compression and depressed profits. The structural advantages of its size and vertical integration allow time to correct mispricing and defend profitability.

UnitedHealth‘s stock has significantly lagged behind competitors like CVS and Centene over the previous year. A detailed examination indicates strong profitability, with an LTM Operating Margin of 6%, combined with a moderate valuation, as reflected by a PE of 17.2 in contrast to CVS's 218.3.